Rodman & Renshaw maintained a Buy rating on Compass Pathways (NASDAQ:CMPS) but significantly reduced the 12-month price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback